AU6798000A - Compounds, compositions and methods for treating influenza - Google Patents
Compounds, compositions and methods for treating influenzaInfo
- Publication number
- AU6798000A AU6798000A AU67980/00A AU6798000A AU6798000A AU 6798000 A AU6798000 A AU 6798000A AU 67980/00 A AU67980/00 A AU 67980/00A AU 6798000 A AU6798000 A AU 6798000A AU 6798000 A AU6798000 A AU 6798000A
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- compounds
- methods
- treating influenza
- influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 206010022000 influenza Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15076399P | 1999-08-26 | 1999-08-26 | |
| US60150763 | 1999-08-26 | ||
| PCT/US2000/023062 WO2001014368A1 (en) | 1999-08-26 | 2000-08-23 | Compounds, compositions and methods for treating influenza |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6798000A true AU6798000A (en) | 2001-03-19 |
Family
ID=22535893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU67980/00A Abandoned AU6798000A (en) | 1999-08-26 | 2000-08-23 | Compounds, compositions and methods for treating influenza |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6798000A (en) |
| WO (1) | WO2001014368A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| CN100350968C (en) | 2001-09-24 | 2007-11-28 | 皇家创新有限公司 | Modification of feeding behavior |
| WO2003057235A2 (en) | 2002-01-10 | 2003-07-17 | Imperial College Innovations Ltd | Modification of feeding behavior |
| GB0300571D0 (en) | 2003-01-10 | 2003-02-12 | Imp College Innovations Ltd | Modification of feeding behaviour |
| US20060035859A1 (en) * | 2003-05-16 | 2006-02-16 | Hemispherx Biopharma | Treating severe and acute viral infections |
| TWI428346B (en) | 2006-12-13 | 2014-03-01 | Imp Innovations Ltd | Novel compounds and their effects on feeding behaviour |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5684024A (en) * | 1996-01-25 | 1997-11-04 | Viropharma Incorporated | Pyrazole dimers compositions and methods for treating influenza |
| US5821243A (en) * | 1996-07-22 | 1998-10-13 | Viropharma Incorporated | Compounds compositions and methods for treating influenza |
-
2000
- 2000-08-23 WO PCT/US2000/023062 patent/WO2001014368A1/en not_active Ceased
- 2000-08-23 AU AU67980/00A patent/AU6798000A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001014368A1 (en) | 2001-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AUPQ127399A0 (en) | Compositions and methods for treating or preventing osteoporosis | |
| AU3998400A (en) | Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor | |
| AU6497600A (en) | Peracid forming system, peracid forming composition, and methods for making and using | |
| AU6908500A (en) | Treatment for narcolepsy | |
| AU8003800A (en) | Methods and compositions for treating neurobehavioral disorders | |
| AU4318000A (en) | Agarobiose-containing composition | |
| AU1290501A (en) | Composition | |
| AU4314199A (en) | Compounds, compositions and methods for treating erectile dysfunction | |
| AU2042301A (en) | 1-aminoalkyl-1H-indoles for treating glaucoma | |
| EP0920419A4 (en) | Compounds, compositions and methods for treating influenza | |
| AU2001275085A1 (en) | Methods, compounds and compositions for treating gout | |
| AU2799900A (en) | Aqueous disinfectant compositions, process for preparing them and their use | |
| AU3896899A (en) | Compositions for the treatment of tumors, and uses thereof | |
| AU3883800A (en) | Hob-bp2h compositions, methods and uses thereof | |
| AU5179800A (en) | Mycolactone and related compounds, compositions and methods of use | |
| AU6798000A (en) | Compounds, compositions and methods for treating influenza | |
| AU7124400A (en) | Radiation-curable, cyanoacrylate-containing compositions | |
| GB9917593D0 (en) | Compound, composition, process and use | |
| AU5704800A (en) | Medicinal compositions for preventing or treating diarrhea | |
| AU2001243297A1 (en) | Method for treating or preventing depression | |
| AU6310600A (en) | Composition | |
| AU4698900A (en) | Pharmaceutical compositions for treating malaria | |
| AU5567600A (en) | Hairdye composition | |
| AU2001211674A1 (en) | Naphthomelanins, process for their preparation and compositions thereof | |
| AU5931300A (en) | Ringene compositions and methods for use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |